In contrast a significant increase in expression of CD24, CD34, CD44 and Oct4 was observed in tumor extracts from animals treated with CIS (6 mg/kg) as compared to mock-treated mice or mice treated with WFA (2 mg/kg) alone. The gene discussed is CD34; the disease is in situ carcinoma.